MedTrace Logo

Pilot Study of BOTOX for Migraine Headaches

NCT00850421 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-09-26

Study results available
· View outcomes & findings →

Summary

The purposes of this study are to assess whether subjects treated with BOTOX will:

1. have a decrease in the frequency and intensity of migraine headaches
2. experience improvements in quality of life
3. experience a reduction in the frequency of health care services obtained.

Conditions

  • Migraine Headache

Interventions

DRUG

Botulinum Toxin Type A

100 Units - Dilution: 25U/ml (4:1 BOTOX/preservative free saline)

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Frederick Taylor, MD · Park Nicollet Health Services

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00850421 on ClinicalTrials.gov